These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 36603179)
1. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline. Vikas P; Messersmith H; Compton C; Sholl L; Broaddus RR; Davis A; Estevez-Diz M; Garje R; Konstantinopoulos PA; Leiser A; Mills AM; Norquist B; Overman MJ; Sohal D; Turkington RC; Johnson T J Clin Oncol; 2023 Apr; 41(10):1943-1948. PubMed ID: 36603179 [TBL] [Abstract][Full Text] [Related]
2. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer. Bartley AN; Mills AM; Konnick E; Overman M; Ventura CB; Souter L; Colasacco C; Stadler ZK; Kerr S; Howitt BE; Hampel H; Adams SF; Johnson W; Magi-Galluzzi C; Sepulveda AR; Broaddus RR Arch Pathol Lab Med; 2022 Oct; 146(10):1194-1210. PubMed ID: 35920830 [TBL] [Abstract][Full Text] [Related]
3. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update. Kalemkerian GP; Narula N; Kennedy EB; Biermann WA; Donington J; Leighl NB; Lew M; Pantelas J; Ramalingam SS; Reck M; Saqi A; Simoff M; Singh N; Sundaram B J Clin Oncol; 2018 Mar; 36(9):911-919. PubMed ID: 29401004 [TBL] [Abstract][Full Text] [Related]
4. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ; J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455 [TBL] [Abstract][Full Text] [Related]
5. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair. Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635 [TBL] [Abstract][Full Text] [Related]
6. Creation of a Quality Payment Program Measure for Mismatch Repair or Microsatellite Instability Biomarker Testing Status in Colorectal, Endometrial, Gastroesophageal, or Small Bowel Carcinoma. Bocsi GT; Laudadio J; Jain R; Eakin SM; Bhalla A; Rosenberg JA; Maratt JK; Kupfer SS; Leiman DA; Cardona DM Arch Pathol Lab Med; 2024 Jun; 148(6):728-734. PubMed ID: 37708308 [TBL] [Abstract][Full Text] [Related]
7. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing. Smithgall MC; Remotti H; Hsiao SJ; Mansukhani M; Liu-Jarin X; Fernandes H Hum Pathol; 2022 Jan; 119():41-50. PubMed ID: 34666078 [TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. Fakhry C; Lacchetti C; Rooper LM; Jordan RC; Rischin D; Sturgis EM; Bell D; Lingen MW; Harichand-Herdt S; Thibo J; Zevallos J; Perez-Ordonez B J Clin Oncol; 2018 Nov; 36(31):3152-3161. PubMed ID: 30188786 [TBL] [Abstract][Full Text] [Related]
9. Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline. de Haas V; Ismaila N; Advani A; Arber DA; Dabney RS; Patel-Donelly D; Kitlas E; Pieters R; Pui CH; Sweet K; Zhang L J Clin Oncol; 2019 Jan; 37(3):239-253. PubMed ID: 30523709 [TBL] [Abstract][Full Text] [Related]
10. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654 [TBL] [Abstract][Full Text] [Related]
11. Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline. Leighl NB; Rekhtman N; Biermann WA; Huang J; Mino-Kenudson M; Ramalingam SS; West H; Whitlock S; Somerfield MR J Clin Oncol; 2014 Nov; 32(32):3673-9. PubMed ID: 25311215 [TBL] [Abstract][Full Text] [Related]
12. Current laboratory testing practices for mismatch repair deficiency and microsatellite instability testing: A survey-based review of current laboratory practices. Austin AL; Broaddus RR; Souers RJ; Kane ME; Kolhe R; Miller DV; Moncur JT; Ramkissoon S; Tafe LJ; Trembath DG; Graham RP Am J Clin Pathol; 2024 Jul; ():. PubMed ID: 39078096 [TBL] [Abstract][Full Text] [Related]
13. Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer. Hill BL; Graf RP; Shah K; Danziger N; Lin DI; Quintanilha J; Li G; Haberberger J; Ross JS; Santin AD; Slomovitz B; Elvin JA; Eskander RN Int J Gynecol Cancer; 2023 Apr; 33(4):504-513. PubMed ID: 36750267 [TBL] [Abstract][Full Text] [Related]
14. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer. Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687 [TBL] [Abstract][Full Text] [Related]
15. Mismatch repair deficiency: The what, how and why it is important. Olave MC; Graham RP Genes Chromosomes Cancer; 2022 Jun; 61(6):314-321. PubMed ID: 34837268 [TBL] [Abstract][Full Text] [Related]
16. Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches. Tan E; Sahin IH Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):735-742. PubMed ID: 33539189 [No Abstract] [Full Text] [Related]
17. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair]. Zhang YH; Wu HW; Wang J; Liang ZY Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):470-475. PubMed ID: 33915653 [No Abstract] [Full Text] [Related]
18. High homogeneity of mismatch repair deficiency in advanced prostate cancer. Fraune C; Simon R; Höflmayer D; Möller K; Dum D; Büscheck F; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Hinsch A; Burandt E; Clauditz TS; Wilczak W; Sauter G; Steurer S Virchows Arch; 2020 May; 476(5):745-752. PubMed ID: 31811435 [TBL] [Abstract][Full Text] [Related]